search
Design Within Reach
Trends
- 1Open-source Covid-19 vaccine PVX-001 enters Phase 1 trial●PVX-001: open-source Covid-19 vaccine starts Phase 1 trial Article URL: https:// chronicles.popvax.com/p/popvax -goes-cl
PopVax's open-source Covid-19 vaccine candidate, PVX-001, has begun Phase 1 clinical trials, marking a step from lab development into human safety testing. The vaccine is being developed with an open-source approach, allowing its designs to be freely shared. Attention has focused on whether an openly developed vaccine can succeed within the traditional clinical trial system.